Pratt S L, Kappes S M, Anthony R V
Department of Animal Sciences, University of Missouri, Columbia 65211, USA.
Domest Anim Endocrinol. 1995 Oct;12(4):337-47. doi: 10.1016/0739-7240(95)00030-i.
Ovine placental lactogen (oPL) exerts actions in sheep and rodent fetal tissues that growth hormone (GH) does not. However, in postnatal tissues, both oPL and GH possess these activities. Although a high-affinity binding site for oPL in ovine fetal liver has been reported, some investigators believe this to be the GH receptor. It was our objective to discriminate between oPL and GH binding to fetal liver microsomes using competitive saturation analyses. Microsomal membranes from fetal liver (Days 60, 90, 105, 120, and 135 of gestation) and postnatal liver (1 wk of age) were incubated with increasing amounts of [125I]oPL in the absence or presence of a 100-fold molar excess of unlabeled oPL. Saturable binding of [125I]oPL was observed with fetal liver and postnatal liver microsomes. The Kd of the oPL-binding site in fetal liver was 122.1 +/- 8.2 pM (mean +/- standard error), and receptor concentrations remained relatively constant (9.8 +/- 1.1 fmol/mg of membrane protein) across gestation. The highest concentration of oPL binding was detected in 1-wk postnatal liver microsomes (53.0 fmol/mg of membrane protein). Saturation analyses using [125I]GH and [125I] prolactin (PRL) were also conducted with fetal liver membrane preparations. Although specific binding for these two radiolabeled ligands was observed in control tissues, no specific binding was observed in fetal liver. These data are in agreement with earlier reports that a high-affinity binding site for oPL exists in fetal tissues. The fact that saturable binding could not be demonstrated for either GH or PRL with fetal liver microsomes contradicts recent suggestions that oPL is binding the GH receptor.
绵羊胎盘催乳素(oPL)在绵羊和啮齿动物胎儿组织中发挥生长激素(GH)所没有的作用。然而,在出生后组织中,oPL和GH都具有这些活性。尽管已报道在绵羊胎儿肝脏中存在oPL的高亲和力结合位点,但一些研究人员认为这是GH受体。我们的目标是通过竞争性饱和分析来区分oPL和GH与胎儿肝脏微粒体的结合。将来自胎儿肝脏(妊娠60、90、105、120和135天)和出生后肝脏(1周龄)的微粒体膜与增加量的[125I]oPL在不存在或存在100倍摩尔过量未标记oPL的情况下孵育。在胎儿肝脏和出生后肝脏微粒体中观察到[125I]oPL的可饱和结合。胎儿肝脏中oPL结合位点的Kd为122.1±8.2 pM(平均值±标准误差),并且整个妊娠期受体浓度保持相对恒定(9.8±1.1 fmol/mg膜蛋白)。在出生后1周的肝脏微粒体中检测到最高浓度的oPL结合(53.0 fmol/mg膜蛋白)。还使用[125I]GH和[125I]催乳素(PRL)对胎儿肝脏膜制剂进行了饱和分析。尽管在对照组织中观察到这两种放射性标记配体的特异性结合,但在胎儿肝脏中未观察到特异性结合。这些数据与早期报道一致,即胎儿组织中存在oPL的高亲和力结合位点。胎儿肝脏微粒体对GH或PRL均未显示可饱和结合这一事实与最近关于oPL与GH受体结合的建议相矛盾。